Miokamycin (MOM), a new macrolide antibiotic, was tested for mutagenicity in the Ames Salmonella test and the dominant lethal assay. MOM was not mutagenic against S. typhimuriu~n strains TA1535' 1538, TA100 and TA98 both with and without activation by S-9 mix. No increases in the frequencies of induced dominant lethal effects were found in MOM treated mice. MOM did not have mutagenic activities on either system. The genetic effects of chemicals are considered to be related to cancer induction or heritable disorder.
The genetic effects of chemicals are considered to be related to cancer induction or heritable disorder.
In this study, we evaluated the mutagenicity of miokamycin (9,3 "-di-O-acetyl midecamycin), a new macrolide antibiotic which was derived from midekamycin. Test systems we used were the Ames Salmonella test with and without metabolic activation and the dominant lethal assay in mice. Materials and Methods
Ames Salmonella Test
Salmonella typhimurium used were histidine auxotroph strains TA1535 1538, TA100 and TA98. TA1535 and TA100 are base pair change and TA1536.'1538 and TA98 are frameshift mutants"2~.
The rat liver microsomal preparation with cofactors (S-9 mix) for metabolic activation was prepared as described by AMES et al. ' MOM suspended in 5 % methanol was tested for mutagenicity quantitatively. Phosphate buffer (pH 7.4) was used as a negative control for the spontaneous reversion of the tester strains. Positive controls for induced reversion employed N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) without metabolic activation and 2-aminoanthracene with S-9 mix. Dominant Lethal Assay Forty adult male mice (ICR-Jcl, 30" 35 g, 10 weeks old) were divided equally into four groups. Each mouse received 600, 1,800 mg MOM (p.o.)/kg, 10 ml distilled water (p.o.)/kg or 250 mg ethyl methanesulfonate (EMS) (i.p.)/kg once before mating. The dose of 1,800 mg MOM (p.o.)/kg is almost one-third the acute oral LD50 in mice. MOM was suspended in distilled water and EMS was dissolved in 5 % DMSO for administrations.
All mice were housed in a SPF experimental room and given sterilized standard food and water ad libitum.
Each male was allowed to mate with three virgin females per week for 8 consecutive weeks. Insemination was determined by the daily examinations on vaginal plugs. Males and mated females were weighed once a week. Mated females were sacrificed on day 14 of gestation. Then, their uteri and ovaries were exposed and examined for numbers of corpora lutea and total, living and dead implantations. Mating and fertility frequencies, rate of females with resorptions, and induced dominant lethality (FL %) were calculated3) . The results of the Ames Salmonella test are given in Table 1 . MNNG at a level of 4 mcg/plate significantly altered the spontaneous revertant frequency in strains TA! 535, TA1538, TA100 and TA98 without metabolic activation. 2-Aminoanthracene at a level of 1 mcg/plate significantly altered spontaneous revertants in strains TA1538, TA100 and TA98 with S-9 mix. MOM did not induce mutants and, in both non-activated and activated systems the numbers of revertants per plate over the concentration range of 3 to 100 mcg did not differ from the control.
No significant differences in body weights of male mice administered distilled water, MOM or EMS were observed. Female mice mated to males administered EMS showed significantly less weight gains at day 14 of gestation during the first 2 weeks of the experimental period. EMS elicited the classical dominant lethal mutations4) . There was an increase in the proportion of pregnant females bearing two or more resorptions, a decrease in live embryo and an increase in pre-implantation losses.
However, MOM did not induce any dominant lethal effects through the experiment. Moreover, When compared to controls through 8 weeks, no significant dominant lethal effects were consequently seen among MOM treated groups.
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